Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

12.42
Delayed Data
As of Aug 12
 +0.25 / +2.06%
Today’s Change
7.36
Today|||52-Week Range
15.25
+5.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization12.0K12.0K254.0K471.0K
 
 
 
 
 
 
Operating ExpensesGross Income-12.0K-12.0K-254.0K-471.0K
 
 
 
 
 
General Expenses21.5M26.1M43.9M67.2M
 
 
 
 
 
Research And Development17.2M20.6M36.1M59.3M
 
 
 
 
 
Total Operating Expenses21.5M26.2M44.1M67.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.5M-26.2M-44.1M-67.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.5M-24.5M-42.4M-65.8M
 
 
 
 
 
Income Taxes-202.0K-131.0K-172.0K-17.0K
 
 
 
 
 
Net Income-20.3M-24.4M-42.6M-65.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.8M48.2M48.5M51.8M
 
 
 
 
 
Shares To Calculate EPS Diluted20.8M48.2M48.5M51.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.97-$0.51-$0.88-$1.27
 
 
 
 
 
EPS Diluted-$0.97-$0.51-$0.88-$1.27